| Sharon L Marble, MD | |
|
8 Waterville Commons Dr, # 312, Waterville, ME 04901-4900 | |
| (207) 730-3260 | |
| (207) 730-3260 |
| Full Name | Sharon L Marble |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 8 Waterville Commons Dr, Waterville, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871864009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD16567 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon L Marble, MD 8 Waterville Commons Dr, # 312, Waterville, ME 04901-4900 Ph: (207) 730-3260 | Sharon L Marble, MD 8 Waterville Commons Dr, # 312, Waterville, ME 04901-4900 Ph: (207) 730-3260 |
News Archive
When young mice with the rodent equivalent of a rare autism spectrum disorder (ASD), called Rett syndrome, were fed a diet supplemented with the synthetic oil triheptanoin, they lived longer than mice on regular diets. Importantly, their physical and behavioral symptoms were also less severe after being on the diet, according to results of new research from The Johns Hopkins University.
For decades, researchers have tried to understand why breast cancer in younger black women is such a significant public health problem.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the "FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data" to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations.
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.
› Verified 9 days ago
Robert Thomas Anderson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136 Fax: 207-872-4522 | |
Robert S Croswell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 30 Chase Ave, Waterville, ME 04901 Phone: 207-872-4397 | |
Dr. Fred A. Bloom, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 67 Silver Street, Waterville, ME 04901 Phone: 207-873-1636 | |
Traci B Schilling, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 180 Kennedy Memorial Dr, Suite 203, Waterville, ME 04901 Phone: 207-861-7050 Fax: 207-861-7056 | |
David N Breer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-861-6854 Fax: 207-861-6815 | |
Paul L Minot, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 30 Chase Ave, Waterville, ME 04901 Phone: 207-861-5232 Fax: 207-861-5233 | |
Marvin A Eisengart, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 325c Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-1990 Fax: 207-877-6639 |